Detalhe da pesquisa
1.
The Cyclooxygenase 2 Inhibitor Etoricoxib as Adjunctive Therapy in Tuberculosis Impairs Macrophage Control of Mycobacterial Growth.
J Infect Dis
; 229(3): 888-897, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37721470
2.
Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients.
J Intern Med
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539241
3.
Circulating markers of extracellular matrix remodelling in severe COVID-19 patients.
J Intern Med
; 294(6): 784-797, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37718572
4.
Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19.
Crit Care
; 27(1): 69, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814280
5.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Crit Care
; 27(1): 9, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627655
6.
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
Proc Natl Acad Sci U S A
; 117(40): 25018-25025, 2020 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32943538
7.
High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19.
J Infect Dis
; 226(12): 2150-2160, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876699
8.
Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations.
J Intern Med
; 291(6): 801-812, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35212063
9.
Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies.
J Intern Med
; 292(5): 816-828, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35982589
10.
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
Ann Intern Med
; 174(9): 1261-1269, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251903
11.
Elevated plasma sTIM-3 levels in patients with severe COVID-19.
J Allergy Clin Immunol
; 147(1): 92-98, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971109
12.
Dyspnoea, lung function and CT findings 3â months after hospital admission for COVID-19.
Eur Respir J
; 57(4)2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33303540
13.
Ventilatory support for hypoxaemic intensive care patients with COVID-19. / Ventilasjonsstøtte for hypoksemiske intensivpasienter med covid-19.
Tidsskr Nor Laegeforen
; 140(11)2020 08 18.
Artigo
em Inglês, Nor
| MEDLINE | ID: mdl-32815344
14.
Gentamicin should remain part of the empirical sepsis regimen for adults. / Gentamicin bør fortsatt inngå i empirisk sepsisregime hos voksne.
Tidsskr Nor Laegeforen
; 144(3)2024 02 27.
Artigo
em Inglês, Nor
| MEDLINE | ID: mdl-38415563
15.
Neutrophil count predicts clinical outcome in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial.
J Intern Med
; 291(2): 241-243, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34411368
16.
We need a new action plan for antibiotic resistance. / Vi trenger en ny handlingsplan mot antibiotikaresistens.
Tidsskr Nor Laegeforen
; 142(11)2022 08 16.
Artigo
em Nor
| MEDLINE | ID: mdl-35997193
17.
The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection.
BMC Infect Dis
; 16(1): 599, 2016 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27776487
18.
Antibiotic use in hospitals in cases of COVID-19. / Antibiotikabruk i sykehus ved covid-19.
Tidsskr Nor Laegeforen
; 140(11)2020 08 18.
Artigo
em Nor
| MEDLINE | ID: mdl-32815355
19.
T.M. Gundem and colleagues respond. / T.M. Gundem og medarbeidere svarer.
Tidsskr Nor Laegeforen
; 140(12)2020 09 08.
Artigo
em Nor
| MEDLINE | ID: mdl-32900164
20.
KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment.
J Infect Dis
; 220(1): 174-176, 2019 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30888024